Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer

Advances in genomics and proteomics drive precision medicine by providing actionable genetic alterations and molecularly targeted therapies, respectively. While genomic analysis and medicinal chemistry have advanced patient stratification with treatments tailored to the genetic profile of a patient&...

Descripción completa

Detalles Bibliográficos
Autores principales: Dasa, Siva Sai Krishna, Diakova, Galina, Suzuki, Ryo, Mills, Anne M., Gutknecht, Michael F., Klibanov, Alexander L., Slack-Davis, Jill K., Kelly, Kimberly A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5957009/
https://www.ncbi.nlm.nih.gov/pubmed/29774075
http://dx.doi.org/10.7150/thno.23050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5957009/
https://www.ncbi.nlm.nih.gov/pubmed/29774075
http://dx.doi.org/10.7150/thno.23050

Ejemplares similares